LOH 19q indicates shorter disease progression-free interval in low-grade oligodendrogliomas with EMP3 methylation.
Pasini A, Iorio P, Bianchi E, Cerasoli S, Cremonini AM, Faedi M, Guarnieri C, Guiducci G, Riccioni L, Molinari C, Rengucci C, Calistri D, Giordano E.
Pasini A, et al. Among authors: giordano e.
Oncol Rep. 2012 Dec;28(6):2271-7. doi: 10.3892/or.2012.2047. Epub 2012 Sep 20.
Oncol Rep. 2012.
PMID: 22992787